Simek I, Kubias K, Duda M
2nd Medical Clinic, Medical Faculty, Palacký University, Olomouc, Czech Republic.
Acta Univ Palacki Olomuc Fac Med. 1993;135:21-3.
The chymotrypsin in the stool test was used to monitor adequate enzymatic substitution in treating exocrine pancreatic insufficiency with 18 patients (16 suffering from chronic pancreatitis and 2 having passed duodenopancreatectomy due to pancreatic cancer). This test helps to identify pancreatic insufficiency and can be successfully used in monitoring the adequate amount of pancreatic substitute, which, we have found, differs from patient to patient. The dosage can be higher in cases of chronic pancreatitis than in those required after duodenopancreatectomy.
粪便检测中的胰凝乳蛋白酶用于监测18例（16例慢性胰腺炎患者和2例因胰腺癌接受十二指肠胰腺切除术者）外分泌性胰腺功能不全治疗中酶替代是否充足。该检测有助于识别胰腺功能不全，并可成功用于监测足够量的胰腺替代物，我们发现，其用量因人而异。慢性胰腺炎患者的用量可能高于十二指肠胰腺切除术后所需的用量。
